Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Sarris

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|December 1, 1996
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
British Journal of Haematology|December 19, 1998
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphomaA Younes, J Romaguera, O Mesina, et al.
Leukemia & Lymphoma|February 26, 1999
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphomaJ E Romaguera, F B Hagemeister, P McLaughlin, et al.
Leukemia & Lymphoma|November 8, 2001
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patientsM Herling, G Z Rassidakis, S Viviani, et al.
Clinical Lymphoma|November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?C Visco, L J Medeiros, O M Mesina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Trimetrexate in relapsed T-cell lymphoma with skin involvementA H Sarris, A Phan, M Duvic, et al.
Investigational New Drugs|January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomasJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.
Leukemia & Lymphoma|June 1, 1997
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphomaA Younes, M A Rodriguez, P McLaughlin, et al.
Leukemia & Lymphoma|September 7, 2000
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patientsJ E Romaguera, I F Khouri, H M Kantarjian, et al.
Oncology (Williston Park, N.Y.)|August 11, 2001
Irinotecan in relapsed or refractory non-Hodgkin's lymphomaA H Sarris, J Romaguera, F B Hagemeister, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|December 1, 1996
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
British Journal of Haematology|December 19, 1998
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphomaA Younes, J Romaguera, O Mesina, et al.
Leukemia & Lymphoma|February 26, 1999
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphomaJ E Romaguera, F B Hagemeister, P McLaughlin, et al.
Leukemia & Lymphoma|November 8, 2001
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patientsM Herling, G Z Rassidakis, S Viviani, et al.
Clinical Lymphoma|November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?C Visco, L J Medeiros, O M Mesina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Trimetrexate in relapsed T-cell lymphoma with skin involvementA H Sarris, A Phan, M Duvic, et al.
Investigational New Drugs|January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomasJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.
Leukemia & Lymphoma|June 1, 1997
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphomaA Younes, M A Rodriguez, P McLaughlin, et al.
Leukemia & Lymphoma|September 7, 2000
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patientsJ E Romaguera, I F Khouri, H M Kantarjian, et al.
Oncology (Williston Park, N.Y.)|August 11, 2001
Irinotecan in relapsed or refractory non-Hodgkin's lymphomaA H Sarris, J Romaguera, F B Hagemeister, et al.
Pageof 6